Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T17:21:31.559Z.
Calculation as of: 2026-10-06T17:21:31.559Z.
Quote observation: 2026-10-06T17:20:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d443e069440aa0ac5a32f25afa0d38c48efe58a411ec60778b8439bb1c5cf92a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Eledon Pharmaceuticals, Inc.
Market Cap
$188.72M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.71M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$181.71M
Price/FCF Ratio
N/A
TTM Avg
28.71
3Y Avg
28.66
5Y Avg
28.66
Market Cap
$175.80M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $188.72M | N/A | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $192.08M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $184.71M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.51M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.71M | N/A | 28.71 | 28.66 | 28.66 |
| Surrozen, Inc. (SRZN)vs › | $198.15M | N/A | N/A | N/A | N/A |
| Exagen Inc. (XGN)vs › | $199.44M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $176.83M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.80M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.29M | N/A | 26.11 | 26.11 | 26.11 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
